• 1
    Harada Y, Iwai M, Kakusui M, et al. Activated hepatic stellate cells participate in liver fibrosis in a patient with transfusional iron overload. J Gastroenterol 1998; 33: 7514.
  • 2
    Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87: 188200.
  • 3
    Saile B, Knittel T, Matthes N, Scott P, Ramadori G. CD95/CD95L-mediated apoptosis of hepatic stellate cells. Am J Pathol 1997; 151: 126572.
  • 4
    Saile B, Matthes N, Knittel T, Ramadori G. TGF-α and TNF-α inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 1999; 30: 196202.
  • 5
    Issa R, Williams E, Trim N, et al. Apoptosis of hepatic stellate cells: involvment in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 2001; 48: 54857.
  • 6
    Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver injury following release of the mechanical stress. Virchows Arch 2003; 442: 37280.
  • 7
    Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study (4S). Lancet 1994; 344: 138389.
  • 8
    Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 13017.
  • 9
    Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med 1996; 335: 10019.
  • 10
    Collins R, Peto R, Armitage J. The MRC/BHF heart protection study: preliminary results. Int J Clin Pract 2002; 53: 536.
  • 11
    Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 288590.
  • 12
    Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACLE study: a randomized controlled trial. JAMA 2001; 285: 17118.
  • 13
    Crouse JR III, Byington RP, Furberg CD. HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis 1998; 138: 1124. Review. Erratum in: Atherosclerosis 1998 September; 140(1): 193–4.
  • 14
    Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The framingham study. Ann Intern Med 1971; 74: 112.
  • 15
    Multiple risk factor intervention trial research group. Multiple risk factor changes and mortality results. JAMA 1982; 248: 146577.
  • 16
    Brown BG, Zhao XQ Importance of endothelial function in mediating the benefits of lipid lowering therapy. Am J Cardiol 1998; 82: 4952T.
  • 17
    Essig M, Nguyen G, Prie D, Escoubet B, Sraer JD, Friedlander G. 3-hydroxy-3- methylglutaryl-CoA reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res 1998; 83: 68390.
  • 18
    Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-hydroxy-3-methylglutaryl(HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1998; 95: 88805.
  • 19
    Sparrow CP, Burton CA, Hernandez M, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001; 21: 11521.
  • 20
    Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001; 103: 27683.
  • 21
    Kwan B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognised type of immunomodulator. Nat Med 2000; 6: 1399402.
  • 22
    Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 42530.
  • 23
    Liao JK. Isoprenoids as mediators of the biological effects of statins. J Clin Invest 2002; 110: 2858.
  • 24
    Roumbouts K, Wielant A, Kisanga E, Hellemans K, Schuppan D, Geerts A. Effects of HMG-CoA reductase inhibitors on proliferation and ECM protein synthesis by rat hepatic stellate cells. J Hepatol 2003; 38: 56472.
  • 25
    De Leeuw AM, McCarthy SP, Geerts A, Knook DL. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology 1984; 4: 392403.
  • 26
    Knook DL, Blansjaar N, Sleyster EC. Isolation and characterization of Kupffer and endothelial cells from the rat liver. Exp Cell Res 1977; 109: 31729.
  • 27
    Yamamoto M, Maehara Y, Sakaguchi Y, Kusumoto T, Ichiyoshi Y, Sugimachi K. Transforming growth factor-beta 1 induces apoptosis in gastric cancer cells through a p53-independent pathway. Cancer 1996; 77: 162833.
  • 28
    Tsutsumi M, Takada A, Takase S. Characterization of desmin-positive rat liver sinusoidal cells. Hepatology 1987; 7: 27784.
  • 29
    Neubauer K, Knittel T, Aurisch S, Fellmer P, Ramadori G. Glial fibrillary acidic protein – a cell type specific marker for Ito cells in vivo and in vitro. J Hepatol 1996; 24: 71930.
  • 30
    Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54: 58999.
  • 31
    Neubauer K, Knittel T, Armbrust T, Ramadori G. Accumulation and cellular localization of fibrinogen/fibrin during short-term and longterm rat liver injury. Gastroenterology 1995; 108: 112435.
  • 32
    Ramadori G, Veit T, Schwogler S, et al. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1990; 59: 34957.
  • 33
    Knittel T, Kobold D, Saile B, et al. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999; 117: 120521.
  • 34
    Saile B, Matthes N, Neubauer K, et al. Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2002; 283: G43544.
  • 35
    Darzynkiewicz Z, Williamson B, Carswell EA, Old LJ. Cell cycle – specific effects of tumor necrosis factor. Cancer Res 1984; 44: 8390.
  • 36
    Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990; 265: 49238.
  • 37
    Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 402935.
  • 38
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 6805.
  • 39
    Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 43504.
  • 40
    Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ. Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol 1996; 36: 6049.
  • 41
    Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 116.
  • 42
    Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999; 6: 102842.
  • 43
    Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 130912.
  • 44
    Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 5139.
  • 45
    Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 47989.
  • 46
    Hu Y, Benedict MA, Ding L, Nunez G. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. EMBO J 1999; 18: 358695.
  • 47
    Zou H, Li Y, Liu X, Wang X. An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biochem Chem 1999; 274: 1154956.
  • 48
    Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1998; 1: 94957.
  • 49
    Pan G, O'Rourke K, Dixit VM. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biochem Chem 1998; 273: 58415.
  • 50
    Gross A, Yin XM, Wang K, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biochem Chem 1999; 274: 115663.
  • 51
    Hermann JL, Bruckheimer E, McDonnell TJ. Cell death signal trasduction and BCL-2 function. Biochem Soc Trans 1999; 24: 105965.
  • 52
    Saile B, DiRocco P, Dudas J. IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). Lab Invest 2004; 84: 103749.
  • 53
    Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268: 145536.
  • 54
    Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995; 270: 148436.
  • 55
    Tuyt LM, Dokter WH, Birkenkamp K. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. J Immunol 1999; 162: 4893902.
  • 56
    Iles KE, Dickinson DA, Wigley AF. HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic Biol Med 2005; 39: 35564.
  • 57
    Ruffels J, Griffin M, Dickenson JM. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death. Eur J Pharmacol 2004; 483: 63173.
  • 58
    Su J-L, Lin MT, Hong CC. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signalling pathway in human leukaemia HL-60 cells. Carcinogenesis 2005; 26: 110.
  • 59
    Soh Y, Jeong KS, Lee IJ. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12. Cells Mol Pharmacol 2000; 58: 53541.
  • 60
    Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G. The Bcl, NFkB and p53/p21WAF1 system are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-alpha and TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol 2001; 80: 55461.